ATAI | AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression
stocktitan.net/news/ATAI/atai-beckley-announc...Posted Nov 10, 2025, 12:00 PM UTC
20